Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 381 - 400 of 485 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
Relapsed/Refractory
[Protocol 12-151]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243]
Dunkel, Ira
  • Germ Cell Tumors
  • Pediatric Brain Tumors
    • CNS Cancer
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097]
Drilon, Alexander
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of SNX-5422 in Patients with Advanced Lung Cancer
[Protocol 13-230]
Drilon, Alexander
  • Lung Cancer, Non-Small Cell
  • Lung Cancer, Small Cell
A Phase I Study of Lurbinectedin plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 13-170]
Drilon, Alexander
  • Breast Cancer
  • Cervical Cancer
  • Germ Cell Tumors
  • Head & Neck Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Solid Tumors
  • Uterine (Endometrial) Cancer
A Phase I Study of BMS-906024 in Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
Relapsed/Refractory
[Protocol 11-181]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Actinium-225-Labeled HuM195 Antibody in Patients with Advanced Myeloid Malignancies
[Protocol 02-017]
Douer, Dan
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
A Phase II Study of a Pediatric-Inspired Combination Chemotherapy Regimen in Adults with Acute Lymphoblastic Leukemia
[Protocol 12-266]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase II Study of PD0332991 in Patients with Advanced or Metastatic Liposarcoma
[Protocol 10-094]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase I/II Study of Lenalidomide in Patients with AIDS-Associated Kaposi's Sarcoma
[Protocol 10-116]
Dickson, Mark
  • AIDS-Associated Cancers
    • AIDS-Associated Kaposi's Sarcoma
A Pilot Trial of Bortezomib in Patients with Relapsed/Refractory AIDS-associated Kaposi Sarcoma
[Protocol 10-117]
Dickson, Mark
  • AIDS-Associated Cancers
    • AIDS-Associated Kaposi's Sarcoma
A Phase I Study of SAR405838 in Patients with Advanced Cancer
[Protocol 13-093]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
  • Solid Tumors
A Phase III Study of BKM120 with Fulvestrant in Postmenopausal Women with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
[Protocol 12-290]
Dickler, Maura
  • Breast Cancer
A Phase II Study of Fulvestrant Alone or with GDC-0941 or GDC-0980 in Women with Advanced Breast Cancer Resistant to Aromatase Inhibitor Therapy
[Protocol 12-029]
Dickler, Maura
  • Breast Cancer
A Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
[Protocol 13-049]
Dickler, Maura
  • Breast Cancer
A Phase II Study of Paclitaxel plus Tivozanib or Placebo in Women with Persistent or Recurrent Triple-Negative Breast Cancer
[Protocol 13-047]
Dickler, Maura
  • Breast Cancer
Two Studies of GDC-0032: A Phase I Study of GDC-0032 for Solid Tumors with Increased PI3K Activity, and a Phase II Study of GDC-0032 with Fulvestrant in Patients with Advanced Breast Cancer
[Protocol 13-149]
Dickler, Maura
  • Breast Cancer
A Phase I Study of BYL719 with Letrozole or Exemestane for Treating Locally Advanced Inoperable or Metastatic Breast Cancer
[Protocol 13-027]
Dickler, Maura
  • Breast Cancer
Prognostic Awareness and Patient-Physician Communication in Malignant Glioma
[Protocol 13-253]
Diamond, Eli
  • Brain Tumors, Primary
    • Gliomas
  • Quality of Life